NASDAQ · Biotechnology

LIXT (LIXT) Stock

$7.21 -6.00% NASDAQ: LIXT Healthcare

Valuation

MetricValue
Price$7.21
Market Cap$89.11M
P/E Ratio-5.30
P/B Ratio7.32
P/S Ratio0.00
EPS (TTM)$-1.26
52-Week High$8.09
52-Week Low$0.68
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-101.95%
ROA-46.00%
ROCE-45.45%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.13
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-7.0M$-6.0M$-5.0M$-4.0M$-5.0M
Net Profit$-7.0M$-6.0M$-5.0M$-4.0M$-6.0M
EPS$-5.00$-4.00$-2.66$-1.59$-1.26
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.0M$6.0M$4.0M$1.0M$13.0M
Total Liabilities$0$0$0$0$2.0M
Cash$5.0M$5.0M$4.0M$1.0M$5.0M
Borrowings$0$0$0$0$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-5.0M$-4.0M$-3.0M$-3.0M
Investing Cash Flow$0$0$0$0$-3.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$1.0M$-1.0M$-3.0M$4.0M
Free Cash Flow$-4.0M$-5.0M$-4.0M$-3.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-5.62%
Quick Ratio2.78
Interest Coverage—
Return 1Y48.34%
Return 3Y14.86%
Return 5Y-78.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLR $1.39 -0.71% -1.91 $22.12M 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%

About LIXT

LIXT is led by CEO Geordan G. Pursglove, employs 2 people, headquartered in US, publicly traded since 2007.

LIXT stock trades at $7.21 with a market capitalization of $89.11M. The stock is valued at a price-to-earnings (P/E) ratio of -5.30, price-to-book of 7.32, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.68 and $8.09, and currently trades 10.9% below its 52-week high.

On profitability, LIXT generates a return on equity (ROE) of -101.95%, return on capital employed of -45.45%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides